Sunday, July 9, 2017, 7:15 a.m. to 8:45 a.m. PT.
Venous thromboembolism (VTE) is a common disorder and a leading cause of death and disability worldwide that affects both hospitalized and non-hospitalized patients. In fact, more than half of VTE events occur after patients are discharged from the hospital. In this live event, Dr Goldhaber and our panel of experts will discuss the critical role clinicians have in assessing VTE risk in medically ill patients, as well as in prescribing appropriate thromboprophylaxis during and after hospitalization to reduce readmissions following hospital discharge. Our panel will also review the management of major bleeds from the use of direct oral anticoagulants (DOACs) in these patients, including the latest data on DOAC antidotes.
Upon completion of this activity, participants will have increased knowledge regarding the:
- Burden of VTE in post-hospital discharge
- Clinical recommendations for VTE prophylaxis in hospitalized medically ill patients
- Latest clinical data on factor Xa inhibitors for extended VTE prophylaxis
This activity is intended for cardiologists, emergency medicine physicians, hematologists, internal medicine physicians, and other healthcare providers involved in the care of patients at risk for VTE.
The goal of this activity is to review the risk of VTE in medically ill patients, the guideline recommendations for thromboprophylaxis during and after hospitalization, as well as the latest clinical data for direct oral anticoagulants (DOACs) in managing this patient population.
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Maximum Of 1.5 AMA PRA Category 1 Credit(s)™
Medscape, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest Statement
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
- Contact Us
- HSAG HIIN
- Medicare Provider Services
- Patients and Families
- ESRD Networks Home
- Medicaid External Quality Review
- National Contracts
- Audit and Validation Services (HEDIS®/P4P)
- Survey Administration
- Other Services